Martha Demski
Director/Board Member at CHIMERIX, INC.
Net worth: 334 542 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Bradbury | M | 62 | 7 years | |
| Michael Andriole | M | 51 | 5 years | |
| Bruce Steel | M | 57 | 7 years | |
| Jack Khattar | M | 62 | 3 years | |
| Michael Sherman | M | 58 | 5 years | |
| Stephen Connelly | M | 42 | 7 years | |
| Stephen Gunstream | M | 45 | 4 years | |
| Damon Terrill | M | 54 | 4 years | |
| Michelle LaSpaluto | F | - | 13 years | |
| Jennifer Henry | F | - | 3 years | |
| Bala S. Manian | M | 77 | 7 years | |
| Roy W. Ware | M | - | 17 years | |
| Charles McDermott | M | 52 | 6 years | |
| Matthew Lowell | M | 53 | 3 years | |
| Alexander Vos | M | 61 | 3 years | |
| Victoria Vakiener | F | 60 | 3 years | |
| Mark Pruzanski | M | 56 | 6 years | |
| Pratik Multani | M | 57 | 4 years | |
| Michael Alrutz | M | 54 | 12 years | |
| Robert Meyer | M | 65 | 6 years | |
| Lisa Decker | M | 55 | 1 years | |
| Michael Moore | M | - | 4 years | |
| Ted Davis | M | - | 28 years | |
| Yu Katherine Xu | M | 52 | 3 years | |
| Fred Middleton | M | 74 | 6 years | |
| Brett Robertson | F | 64 | 3 years | |
| Barbara Troupin | M | 56 | 2 years | |
| Clarence Machado | M | 60 | 10 years | |
| David Jakeman | M | 47 | 15 years | |
| Matthew MacKowski | M | 68 | 5 years | |
| Maple Fung | M | - | 4 years | |
| Allen Melemed | M | 60 | 4 years | |
| Caryn Barnett | F | - | 4 years | |
| Michael Goldstein | M | - | 3 years | |
| Ron LeTendre | M | - | 4 years | |
| Irene Davis | F | 64 | 9 years | |
| Christopher L. Jordan | M | - | 2 years | |
| Jose Olague | M | - | 4 years | |
| Odin Naderer | M | - | 10 years | |
| Cherie Ng | F | - | - | |
| Bryan A. Roecklein | M | - | 3 years | |
| Joshua Allen | M | - | 3 years | |
| Harjit Kullar | M | - | 4 years | |
| Thomas Riga | M | 48 | 1 years | |
| Christine Zedelmayer | F | 54 | 6 years | |
| Kristin DeFife | M | - |
Ajinomoto Althea, Inc.
 Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | 12 years |
| Young Kwon | M | 52 | 3 years | |
| Matthew R. Ritter | M | - | - | |
| Alexander Herzick | M | 43 | 5 years | |
| Joel Rothman | M | 55 | 6 years | |
| Paul Grossman | M | 63 | - | |
| Cindy Petersen | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George R. Painter | M | - | 12 years | |
| Gregory T. Went | M | 60 | 19 years | |
| Kenneth Moch | M | 69 | 5 years | |
| Vijay Samant | M | 77 |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 19 years |
| George W. Mahaffey | M | 65 |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | 5 years |
| François Ferré | M | 66 |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | 15 years |
| Timothy J. Wollaeger | M | 80 | 16 years | |
| James Niedel | M | 79 | 7 years | |
| John D. Dobak | M | 58 |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | 7 years |
| Alan Rappaport | M | 71 |
US Trust
| - |
| Seth A. Rudnick | M | 75 | - | |
| David Mahoney | M | 69 | 12 years | |
| M. Berrey | M | 57 | 7 years | |
| Jennifer J. Rhodes | F | 53 | - | |
| Mardi Dier | F | 60 | 4 years | |
| Larry Smith | M | 63 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 16 years |
| Robert C. Merton | M | 79 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 17 years |
| Alan R. Engbring | M | - |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 17 years |
| Hervé Momméja-Marin | M | 53 | - | |
| Edward F. Greissing | M | 73 | 3 years | |
| Robert McNamara | M | 67 | 2 years | |
| Ashleigh Barreto | F | - | - | |
| Keith D. Hall | M | 62 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 15 years |
| Timothy Trost | M | 66 | 7 years | |
| Christopher B. Prentiss | M | 49 | 6 years | |
| Wende Hutton | F | 63 | - | |
| Alfred G. Merriweather | M | 70 | 2 years | |
| Grace U. Shin | F | 59 | - | |
| Bob H. Campbell | M | 86 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 10 years |
| Ronald Renaud | M | 55 | 6 years | |
| Gary Lyons | M | 73 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 22 years |
| Joseph T. Schepers | M | 65 | 3 years | |
| Daniel Janney | M | 58 |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | 8 years |
| John A. MacPhee | M | 56 | 8 years | |
| Jeffrey H. Knapp | M | 58 | 2 years | |
| Lisa Ricciardi | F | 64 | - | |
| Ernest Mario | M | 85 | - | |
| Art Pappas | M | 76 | 3 years | |
| Michael Bigham | M | 66 | 5 years | |
| Bill Ericson | M | 65 | 16 years | |
| J. Enloe | M | 60 |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | 7 years |
| William Dawson | M | 69 | 3 years | |
| R. Gordon Douglas | M | 89 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 20 years |
| Ivan M. Lieberburg | M | 74 | 16 years | |
| Jeffrey M. Nugent | M | 76 |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | - |
| Dov Goldstein | M | 56 | 13 years | |
| Richard H. Booth | M | 77 | 3 years | |
| Spyridon Papapetropoulos | M | 52 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martha Demski
- Personal Network